title: Reply.
authors.affiliation: Yokohama, Japan.
authors.forename: Maiko
authors.initials: M
authors.lastname: Maruyama-Inoue
authors.affiliation: Yokohama, Japan.
authors.forename: Shin
authors.initials: S
authors.lastname: Yamane
authors.affiliation: Yokohama, Japan.
authors.forename: Shimpei
authors.initials: S
authors.lastname: Sato
authors.affiliation: Yokohama, Japan.
authors.forename: Kazuaki
authors.initials: K
authors.lastname: Kadonosono
mesh_terms: D006801:Humans; D008268:Macular Degeneration; D000069579:Ranibizumab; D040262:Receptors, Vascular Endothelial Growth Factor; D011993:Recombinant Fusion Proteins; D019233:Retreatment
chemical_list: D011993:Recombinant Fusion Proteins; C533178:aflibercept; D040262:Receptors, Vascular Endothelial Growth Factor; D000069579:Ranibizumab